Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,175 trials

NCT07211178
Recruiting
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
Not applicable · United States · 16 sites
Registry update: 3 Sept 2026
NCT07270172
Recruiting
The MICRON Study - A Steno 1 Substudy
Not applicable · Denmark · 5 sites
Registry update: 2 Feb 2026
NCT07033117
Recruiting
RaDIANT Health Systems Intervention
Not applicable · United States · 5 sites
Registry update: 26 May 2026
NCT07381829
Recruiting
A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combined With Chemotherapy in Lung Cancer
Phase 1 · China · 1 site
Registry update: 2 Feb 2026
2025-522503-18-00
Recruiting
Semaglutide and Finerenone for Kidney and Vascular Protection in CKD
Phase 4 · Denmark · 2 sites
Registry update: 9 Sept 2025
2024-519929-38-00
Recruiting
– IKF/AIO-QUINTIS – A Randomized Phase II Trial Evaluating Fruquintinib in Combination with Tislelizumab in Microsatellite Stable / Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Cancer without Active Liver Metastases
Phase 2 · Austria, Germany · 31 sites
Registry update: 8 Jun 2026
NCT06176690
Recruiting
Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas
Phase 1 · United States · 2 sites
Registry update: 2 Oct 2026
NCT06848491
Recruiting
Using Tailored mHealth Strategies to Promote Weight Management Among Adolescent and Young Adult Cancer Survivors
Not applicable · United States · 1 site
Registry update: 24 Aug 2026
NCT07436143
Recruiting
Effects of Posture and Quality of Life in Duchenne Muscular Dystrophy Children
Not applicable · Pakistan · 1 site
Registry update: 27 Feb 2026
NCT07282184
Recruiting
Multimodal Deep Learning for Postoperative Liver Cancer Risk Stratification and Intervention
Phase 1/2 · China · 1 site
Registry update: 18 Dec 2025
NCT07173205
Recruiting
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
Not applicable · United States · 2 sites
Registry update: 7 Jan 2026
NCT06804135
Recruiting
Systemic and Tumor Immune Response During Pelvic (Chemo)Radiation and/or Brachytherapy for Cervical Cancer
Not applicable · India · 1 site
Registry update: 4 Feb 2026
NCT07296705
Recruiting
Neoadjuvant Zanidatamab + Tislelizumab + Chemotherapy for Selective Bladder Preservation in HER2-Positive MIBC
Phase 2 · China · 12 sites
Registry update: 22 Dec 2025
NCT07652125
Recruiting
RGL-270 + ICI in Advanced NSCLC
Not applicable · China · 1 site
Registry update: 30 Jun 2026
NCT07250893
Recruiting
Resolving Early Life Stress: Psychotherapy Outcomes and Neurobiology in Complex Depression
Not applicable · Canada · 1 site
Registry update: 14 Jul 2026
NCT07881666
Recruiting
Inactivated UPEC-FimON for Non Muscle Invasive Bladder Cancer After BCG or Intravesical Chemotherapy Failure
Phase 1 · Israel · 3 sites
Registry update: 30 Oct 2026
NCT07048535
Recruiting
CAR T-cell Long-Term Follow-Up, Quality of Life and Adverse Reactions
Not applicable · United States · 1 site
Registry update: 29 Apr 2026
NCT07350954
Recruiting
Acceptability and Feasibility of a Brief Paranoia Intervention.
Not applicable · United Kingdom · 1 site
Registry update: 20 Jan 2026
NCT07221227
Recruiting
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Phase 3 · Australia, Canada, Hong Kong, Japan, New Zealand, Puerto Rico, Saudi Arabia, Taiwan, United States · 77 sites
Registry update: 27 Jul 2026
NCT07171606
Recruiting
A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer（NSCLC） Patients
Phase 2 · China · 1 site
Registry update: 18 Dec 2025

Ordered by registry start date. Freshness and sponsorship never change the order.